首页> 外文期刊>Molecular therapy: the journal of the American Society of Gene Therapy >Functional cone rescue by RdCVF protein in a dominant model of retinitis pigmentosa.
【24h】

Functional cone rescue by RdCVF protein in a dominant model of retinitis pigmentosa.

机译:在色素性视网膜炎的显性模型中,通过RdCVF蛋白进行功能性圆锥拯救。

获取原文
获取原文并翻译 | 示例
       

摘要

In retinitis pigmentosa (RP), a majority of causative mutations affect genes solely expressed in rods; however, cone degeneration inevitably follows rod cell loss. Following transplantation and in vitro studies, we demonstrated the role of photoreceptor cell paracrine interactions and identified a Rod-derived Cone Viability Factor (RdCVF), which increases cone survival. In order to establish the clinical relevance of such mechanism, we assessed the functional benefit afforded by the injection of this factor in a frequent type of rhodopsin mutation, the P23H rat. In this model of autosomal dominant RP, RdCVF expression decreases in parallel with primary rod degeneration, which is followed by cone loss. RdCVF protein injections induced an increase in cone cell number and, more important, a further increase in the corresponding electroretinogram (ERG). These results indicate that RdCVF can not only rescue cones but also preserve significantly their function. Interestingly, the higher amplitude of the functional versus the survival effect of RdCVF on cones indicates that RdCVF is acting more directly on cone function. The demonstration at the functional level of the therapeutic potential of RdCVF in the most frequent of dominant RP mutations paves the way toward the use of RdCVF for preserving central vision in many RP patients.
机译:在色素性视网膜炎(RP)中,大多数致病性突变会影响仅在杆中表达的基因。然而,视锥变性不可避免地伴随着杆状细胞的损失。在进行移植和体外研究之后,我们证明了感光细胞旁分泌相互作用的作用,并鉴定了杆衍生的圆锥生存力因子(RdCVF),从而提高了圆锥的存活率。为了建立这种机制的临床相关性,我们评估了在常见类型的视紫红质突变(P23H大鼠)中注射该因子所提供的功能益处。在这种常染色体显性RP模型中,RdCVF的表达与原发性棒变性同时下降,随后是视锥细胞丢失。注射RdCVF蛋白引起视锥细胞数量增加,更重要的是,相应的视网膜电图(ERG)进一步增加。这些结果表明,RdCVF不仅可以拯救视锥细胞,而且可以显着保留其功能。有趣的是,RdCVF对锥体的功能与生存效应的幅度越大,表明RdCVF对锥体功能的作用越直接。在功能水平上,RdCVF在最常见的显性RP突变中具有治疗潜力,这为在许多RP患者中使用RdCVF保持中心视力铺平了道路。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号